Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer's Disease. (Q50436669)

14 March 2018

title

Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer's Disease. (English)

1 reference

14 March 2018

1 reference

Jonatan A Snir

1

1 reference

14 March 2018

Mojmir Suchy

2

1 reference

14 March 2018

Keith St Lawrence

3

1 reference

14 March 2018

Robert H E Hudson

4

1 reference

14 March 2018

Stephen H Pasternak

5

1 reference

14 March 2018

Robert Bartha

6

1 reference

14 March 2018

publication date

1 August 2015

1 reference

14 March 2018

Journal of Alzheimer's Disease

published in

1 reference

14 March 2018

volume

48

1 reference

14 March 2018

issue

1

1 reference

14 March 2018

page(s)

73-87

1 reference

14 March 2018

2014 Alzheimer's disease facts and figures

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Neuropathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Cerebrovascular disorders: molecular insights and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Biomarker-driven therapeutic management of Alzheimer's disease: establishing the foundations

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Biomarkers in Alzheimer's disease: not yet surrogate endpoints.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Alzheimer's disease drug-development pipeline: few candidates, frequent failures

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Successes and failures for drugs in late-stage development for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Trajectories of brain loss in aging and the development of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Brain function during multi-trial learning in mild cognitive impairment: a PET activation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

PET imaging of amyloid deposition in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Tau PET imaging in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Synthesis and preliminary evaluation of 2-arylhydroxyquinoline derivatives for tau imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Frequent amyloid deposition without significant cognitive impairment among the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Cathepsin D--many functions of one aspartic protease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Animal models of neurodegenerative disease: insights from in vivo imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Brain glucose hypometabolism after perirhinal lesions in baboons: implications for Alzheimer disease and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Characteristics of compounds that cross the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Permeability of the blood-brain barrier to HIV-1 Tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

The use of cell-penetrating peptides for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Cell-penetrating peptides and peptide nucleic acid-coupled MRI contrast agents: evaluation of cellular delivery and target binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

A paramagnetic chemical exchange-based MRI probe metabolized by cathepsin D: design, synthesis and cellular uptake studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

A dual magnetic resonance imaging/fluorescent contrast agent for Cathepsin-D detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Near infrared fluorescent optical imaging for nodal staging

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Near-infrared-labeled tetracycline derivative is an effective marker of bone deposition in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

The pharmacokinetics of cell-penetrating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

Lipid Solubility and Drug Penetration of the Blood Brain Barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150123

21 January 2018

Identifiers

DOI

10.3233/JAD-150123

1 reference

14 March 2018

PubMed ID

26401930

1 reference

14 March 2018